Skip to Content

Zhejiang Xianju Pharmaceutical, China, 2025


GMP Audit Report

Company
Zhejiang Xianju Pharmaceutical

Product(s)
Mifepristone

Country
China

Audit Year
2025

0.00 € 0.00 €
0.00 €